蝶腭穴针刺治疗持续性变应性鼻炎的随机对照试验
该随机对照试验将61例持续性变应性鼻炎(PAR)患者随机分为针刺组与假针刺组,两组针刺深度分别为50 mm与20 mm。主要结局为鼻症状总分(TNSS)变化,结果显示治疗组第4周TNSS显著低于对照组,第12周两组无显著差异;治疗组第2周生活质量(RQLQ)显著改善,随访期用药剂量显著低于对照组,两组均未观察到不良事件。
要点
- 针刺蝶腭穴(深度50 mm)治疗PAR,第4周TNSS显著低于假针刺组(深度20 mm)。
- 治疗组第2周RQLQ评分显著优于对照组,随访期用药剂量显著低于对照组。
- 两组治疗期间均未观察到不良事件。
核心结论
- 该初步研究显示蝶腭穴针刺对预防PAR发展有显著效果,治疗组(针刺深度50 mm)TNSS显著低于对照组(针刺深度仅20 mm)。
- 结果证明直接在蝶腭穴针刺刺激蝶腭神经节是治疗PAR的有效方法。
研究设计与样本
- 随机对照试验,共61例诊断为持续性变应性鼻炎(PAR)的患者随机分配至针刺组或假针刺组。
- 两组区别为针刺深度,分别为50 mm和20 mm。
- 主要结局为鼻症状总分(TNSS)变化;次要结局包括生活质量、用药剂量和不良事件,生活质量采用鼻结膜炎生活质量问卷(RQLQ)测量。
主要发现
- 第4周治疗组平均TNSS显著低于对照组,中位数(第25、75百分位数)分别为5.00(4.00,7.00)和8.00(7.00,10.00),P < 0.001。
- 第12周两组TNSS评分无显著差异。
- 第2周治疗组RQLQ评分较对照组显著改善,分别为35.47 ± 8.20和45.48 ± 8.84,P < 0.001。
- 随访期间治疗组用药剂量显著低于对照组,分别为3.64 ± 1.45和6.14 ± 2.34,P < 0.05。
- 治疗期间两组均未观察到不良事件。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Allergic rhinitis is a common respiratory disease. Acupuncture is used to treat it in traditional Chinese medicine, and generally, the L120, ST2 and ST36 acupoints are selected in clinical practice. We report a new method of acupuncture at the sphenopalatine acupoint (SPA) for treatment of persistent allergic rhinitis (PAR). The effect of this treatment was investigated using two different needling depths. The efficacy of this treatment was associated with accurate stimulation of the sphenopalatine ganglion (SPG). METHODS/DESIGN: A total of 61 patients diagnosed with PAR were randomly allocated to either the acupuncture or the sham acupuncture group. The difference between the groups was the needle depth when acupuncture was administered, which was 50 mm and 20 mm. Alteration in total nasal symptom score (TNSS) was the primary outcome. Quality of life, medication dosages and adverse events were secondary outcomes, measured using the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ). Confidence assessment was performed to evaluate data from the treatment and follow-up periods. RESULTS: Results were: (1) average TNSS in the treatment group was significantly lower than in the control group at week 4 (median and 25th and 75th percentiles were 5.00 (4.00, 7.00) and 8.00 (7.00, 10.00), respectively (P < 0.001)). However, scores in the two groups were not significantly different at week 12; (2) quality of life (RQLQ) was significantly improved at week 2 in the treatment group compared to the control group (scores of 35.47 ± 8.20 and 45.48 ± 8.84; P < 0.001); (3) during the follow-up period, the medication dosage in the treatment group was much lower than in the control group (3.64 ± 1.45 and 6.14 ± 2.34; P < 0.05); and (4) no adverse events were observed in either group during treatment. CONCLUSIONS: This pilot study revealed a profound effect of acupuncture at the SPA on prevention of PAR development. The TNSS in the treatment group (needle depth 50 mm), was significantly lower than in the control group (needle depth of only 20 mm). Our result demonstrates that performing acupuncture directly at the SPA to stimulate the SPG is an effective method to treat PAR. TRIAL REGISTRATION: Acupuncture Clinical Trial Registry, AMCTR-OOR-16000014 and Chinese Clinical Trial Register, ChiCTR-IOR-16009211 . Registered on 1 September 1 2016.
引用
- Mi J, Chen X, Lin X, et al. Treatment of persistent allergic rhinitis via acupuncture at the sphenopalatine acupoint: a randomized controlled trial. Trials. 2018. PMID: 29325594. doi:10.1186/s13063-017-2339-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。